text
stringlengths 1
711
|
|---|
Figure 46: EBITDA Margins vs. Peers
|
CY22
|
-10%
|
-5%
|
0%
|
5%
|
10%
|
15%
|
20%
|
25%
|
30%
|
RKT HLN PG KVUE CL OR CHD ELF EL COTY ULVR KMB BEI CLX NWL HNST
|
EBITDA Margin Average Median
|
Source: Company reports and J.P. Morgan estimates.; *OLPX EBITDA Margin 60.9% removed for ease of comparison.
|
Balance Sheet, FCF, CapEx
|
Following the companys IPO, balance sheet leverage is around 2.1x net debt to trailing
|
12-month adjusted EBITDA (or roughly 2.4-2.5x gross debt to trailing 12-month
|
adjusted EBITDA) assuming roughly $9.0 billion in senior notes and commercial paper
|
and roughly $1.2 billion in cash. With EBITDA growth and strong FCF generation, we
|
see KVUE deleveraging to around 1.8x net debt to BITDA by 2024 and 1.6x by 2025.
|
The company could potentially delever faster (or increase cash returns to shareholders)
|
in the event it doesnt pursue acquisitions as we believe the company is building in
|
cushion to its cash/balance sheet outlook to accommodate bolt-on M&A. Relative to its
|
peer set, KVUEs balance sheet leverage is largely middle of the pack with PG (1.2x)
|
and CL (1.6x) lower and HLN (3.6x) higher.
|
Figure 47: KVUE Leverage Outlook
|
2.4x
|
2.2x
|
2.1x
|
1.9x
|
2.1x
|
2.0x
|
1.8x
|
1.6x
|
0.0x
|
0.5x
|
1.0x
|
1.5x
|
2.0x
|
2.5x
|
3.0x
|
Post-IPO 2023E 2024E 2025E
|
Gross Debt to EBITDA Net Debt to EBITDA
|
Source: Company reports and J.P. Morgan estimates.
|
This document is being provided for the exclusive use of DAVID WANG at MARLOWE PARTNERS LP.
|
31
|
Andrea Teixeira, CFA AC
|
(1-212) 622-6735
|
andrea.f.teixeira@jpmorgan.com
|
North America Equity Research
|
29 May 2023 J P M O R G A N
|
From a free cash flow perspective, the company is targeting >100% FCF conversion (%
|
of adjusted net income) in each of 2023-2025, and we model for free cash flow to grow
|
at a three-year CAGR of +11% to $2.8 billion in 2025. The free cash flow outlook is
|
supported by solid adjusted EBITDA growth (as described above) and some tailwind
|
from working capital management as inventory normalizes following a step-up in 2022
|
(more below), which more than offsets cash separation costs expected to be incurred
|
from 2023-2025 (around $595M post-tax) and some step-up in capital expenditures.
|
We note that 2022 was a tougher year from a cash flow perspective (FCF conversion
|
79% and overall FCF -27% YOY) as the company had a significant working capital
|
headwind due to supply chain disruption, inflation, and also building inventory ahead of
|
the JNJ separation (safety stock). As we mentioned, we expect inventory normalization
|
to be a tailwind to free cash flow ahead, and we model for working capital as a percent
|
of sales to decline from 16.8% in 2022 to 13.5% in 2025.
|
Figure 48: KVUE Free Cash Flow Outlook
|
0%
|
20%
|
40%
|
60%
|
80%
|
100%
|
120%
|
$0
|
$500
|
$1,000
|
$1,500
|
$2,000
|
$2,500
|
$3,000
|
2021 2022 2023E 2024E 2025E
|
FCF $m (left-axis) FCF % of adj. Net Income (right-axis)
|
Source: Company reports and J.P. Morgan estimates.
|
Figure 49: KVUE Working Capital Outlook
|
17.7%
|
13.6% 12.9%
|
16.8%
|
15.2%
|
14.0% 13.5%
|
0.0%
|
2.0%
|
4.0%
|
6.0%
|
8.0%
|
10.0%
|
12.0%
|
14.0%
|
16.0%
|
18.0%
|
20.0%
|
$0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.